Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Efficacy and safety of immunotherapy with interferon-gamma in the management of chronic sulfur mustard-induced cutaneous complications: comparison with topical betamethasone 1%.

Panahi Y, Sahebkar A, Davoudi SM, Amiri M, Beiraghdar F.

ScientificWorldJournal. 2012;2012:285274. doi: 10.1100/2012/285274. Epub 2012 Mar 12.

2.

Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard.

Panahi Y, Davoudi SM, Beiraghdar F, Amiri M.

Skinmed. 2011 May-Jun;9(3):152-8.

PMID:
21675494
3.

Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial.

Panahi Y, Davoudi SM, Sahebkar A, Beiraghdar F, Dadjo Y, Feizi I, Amirchoopani G, Zamani A.

Cutan Ocul Toxicol. 2012 Jun;31(2):95-103. doi: 10.3109/15569527.2011.614669. Epub 2011 Oct 12.

PMID:
21988705
4.

Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure.

Panahi Y, Davoudi SM, Moharamzad Y, Beiraghdar F, Naghizadeh MM.

Cutan Ocul Toxicol. 2008;27(3):203-11. doi: 10.1080/15569520802143519.

PMID:
18988089
5.

Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.

Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM.

Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):171-5. doi: 10.1111/j.1742-7843.2008.00356.x. Epub 2008 Dec 18.

6.

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M.

Br J Nutr. 2012 Oct;108(7):1272-9. Epub 2011 Nov 18.

PMID:
22099425
7.

Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis.

Panahi Y, Davoudi SM, Madanchi N, Abolhasani E.

Clin Exp Med. 2012 Dec;12(4):241-5. doi: 10.1007/s10238-011-0164-3. Epub 2011 Nov 19.

PMID:
22101570
8.

Baicalin as a potentially promising drug for the management of sulfur mustard induced cutaneous complications: a review of molecular mechanisms.

Sahebkar A.

Cutan Ocul Toxicol. 2012 Sep;31(3):226-34. doi: 10.3109/15569527.2011.633950. Epub 2011 Nov 22. Review.

PMID:
22107027
9.

Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure.

Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M.

Singapore Med J. 2007 May;48(5):392-5.

10.

Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure.

Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M.

Int J Dermatol. 2006 Sep;45(9):1025-31.

PMID:
16961503
11.

Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans.

Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M.

Int J Dermatol. 2008 Jun;47(6):557-61. doi: 10.1111/j.1365-4632.2008.03650.x.

PMID:
18477143
12.

Comparative study of Unna's Boot and betamethasone cream in the treatment of sulfur mustard-related pruritus.

Shohrati M, Davoudi M, Almasi M, Sadr B, Peyman M.

Cutan Ocul Toxicol. 2007;26(4):303-9.

PMID:
18058305
13.

Effect of recombinant human IFN╬│ in the treatment of chronic pulmonary complications due to sulfur mustard intoxication.

Panahi Y, Ghanei M, Vahedi E, Ghazvini A, Parvin S, Madanchi N, Bagheri M, Sahebkar A.

J Immunotoxicol. 2014 Jan-Mar;11(1):72-7. doi: 10.3109/1547691X.2013.797525. Epub 2013 Jun 14.

PMID:
23768082
14.

Historical perspective on effects and treatment of sulfur mustard injuries.

Graham JS, Schoneboom BA.

Chem Biol Interact. 2013 Dec 5;206(3):512-22. doi: 10.1016/j.cbi.2013.06.013. Epub 2013 Jun 28. Review.

PMID:
23816402
15.

Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study.

Panahi Y, Taherzadeh ES, Davoudi SM, Sahebkar A, Ranjbar R.

Cutan Ocul Toxicol. 2013 Mar;32(1):4-8. doi: 10.3109/15569527.2012.686077. Epub 2012 Jun 11.

PMID:
22681041
16.

Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications.

Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M.

Clin Exp Ophthalmol. 2006 May-Jun;34(4):342-6.

PMID:
16764654
17.

Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years.

Ghanei M, Panahi Y, Mojtahedzadeh M, Khalili AR, Aslani J.

Pulm Pharmacol Ther. 2006;19(2):148-53. Epub 2005 Aug 30.

PMID:
16137903
18.

Acute and chronic effects of sulfur mustard on the skin: a comprehensive review.

Ghanei M, Poursaleh Z, Harandi AA, Emadi SE, Emadi SN.

Cutan Ocul Toxicol. 2010 Dec;29(4):269-77. doi: 10.3109/15569527.2010.511367. Epub 2010 Sep 24. Review.

PMID:
20868209
19.

Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions.

Wormser U, Sintov A, Brodsky B, Casillas RP, Nyska A.

Arch Toxicol. 2004 Mar;78(3):156-66. Epub 2003 Nov 15.

PMID:
14618300
20.

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

Panahi Y, Sahebkar A, Parvin S, Saadat A.

Ann Clin Biochem. 2012 Nov;49(Pt 6):580-8. doi: 10.1258/acb.2012.012040. Epub 2012 Oct 4.

PMID:
23038702

Supplemental Content

Support Center